Project Grant HT94252410426
Award Date
9/30/24
Completion Date
9/29/28
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Awardee
Dignity Health (SKX6AXF9ZTM3)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94107, USA
Similar Awards
The Department of the Army Medical Command awarded a $722,545 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Dignity Health's St. Joseph's Hospital and Medical Center in San Francisco, CA. The grant will fund a 2-year research project to investigate the role of TDP-43 associated cryptic exon inclusion in C9ORF72-mediated cortical neurodegeneration. The project aims to advance understanding of the molecular mechanisms underlying neurological disorders...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,487,072.00 to Dignity Health's St. Joseph's Hospital and Medical Center in Phoenix, AZ to develop a novel bifunctional agent as a radiosensitizer for glioblastoma and a radioprotector of normal brain. The award has an initial term from August 15, 2024 to August 14, 2027. The key products or services to be delivered through this funding include...
This $649,762 federal Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research by Dignity Health's St. Joseph's Hospital and Medical Center (Barrow Neurological Institute) to investigate maladaptive 5-HT raphe-corticolimbic plasticity underlying the development of non-motor symptoms in Parkinson's disease. The award period runs from September 30, 2024 through September 29, 2028. As a prime recipient,...
This federal Project Grant award, totaling $655,380, was provided by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to Dignity Health's St. Joseph's Hospital and Medical Center (also known as Barrow Neurological Institute) to conduct research on maladaptive 5-HT raphe-corticolimbic plasticity underlying the development of non-motor symptoms in Parkinson's disease. The project will be performed in...
The Washington University Office of Sponsored Research Services Division was awarded a $1,377,119 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct the study "AD GENETIC RISK AS A PROGNOSTIC FACTOR FOR COGNITIVE OUTCOMES AFTER TBI" over a 4-year period from September 2024 to September 2028. This federal grant supports innovative biomedical research aimed at improving health outcomes for military service...
The Defense Health Agency awarded Massachusetts General Hospital a $368,238 project grant under the Military Medical Research and Development program (CFDA 12.420) from September 1, 2023 through August 31, 2026. The grant will fund research to determine if microbiome-derived cell fragments in the brain accelerate transition from traumatic brain injury to Alzheimer's disease or related dementias. As a leading academic medical center, Massachusetts General Hospital will leverage its expertise in...
The U.S. Defense Health Agency awarded a $1,607,403 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the East Bay Institute for Research & Education Inc., a non-profit organization located in Mather, California. The grant supports a longitudinal study monitoring cognitive changes in older veterans using telehealth-based computerized neuropsychological assessments. The project aims to develop innovative, non-pharmacological approaches to understanding...
The University of Arizona, through the Arizona Board of Regents, was awarded a $3,004,651 Project Grant from the Defense Health Agency to develop a treatment for neuropsychological and memory impairments following moderate to severe traumatic brain injury. This grant, awarded under the Military Medical Research and Development (CFDA 12.420) program, funds a research project aimed at advancing scientific understanding and improving patient care for service members and veterans affected by...
This Project Grant award of $680,458.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is supporting Dignity Health's Mercy Hospital in San Francisco to conduct research on "ENHANCING ACMSD ACTIVITY AS A NOVEL GENE THERAPY FOR ALS." The research aims to transform healthcare for service members, veterans, and the public through innovative biomedical research on neurodegenerative diseases like amyotrophic lateral sclerosis...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,314,065.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the "Dose-Response Relationship of Acute TBI Blood Biomarkers with Pathoanatomic Neuroimaging Findings". The research aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical research on...